Searched for: school:SOM
Department/Unit:Neurology
Challenges in the neuropsychological assessment of ethnic minorities
Chapter by: Rabin, Laura A; Brodale, Donald L; Elbulok-Charcape, Milushka M; Barr, William B
in: Clinical cultural neuroscience: An integrative approach to cross-cultural neuropsychology by Pedraza, Otto [Ed]
New York, NY, US: Oxford University Press, 2020
pp. 55-80
ISBN: 9780190619305
CID: 4374302
RITUXIMAB AND PREGNANCY IN NEUROIMMUNOLOGICAL DISORDERS: A RETROSPECTIVE STUDY [Meeting Abstract]
Ge, Lily; Kister, Ilya; Charlson, Robert; Howard, Jonathan; Krupp, Lauren; Ryerson, Lana Zhovtis
ISI:000536058004004
ISSN: 0028-3878
CID: 5192122
Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models
Yu, Y Eugene; Xing, Zhuo; Do, Catherine; Pao, Annie; Lee, Eun Joon; Krinsky-McHale, Sharon; Silverman, Wayne; Schupf, Nicole; Tycko, Benjamin
The presence of an extra copy of human chromosome 21 (Hsa21) leads to a constellation of phenotypic manifestations in Down syndrome (DS), including prominent effects on the brain and immune system. Intensive efforts to unravel the molecular mechanisms underlying these phenotypes may help developing effective therapies, both in DS and in the general population. Here we review recent progress in genetic and epigenetic analysis of trisomy 21 (Ts21). New mouse models of DS based on syntenic conservation of segments of the mouse and human chromosomes are starting to clarify the contributions of chromosomal subregions and orthologous genes to specific phenotypes in DS. The expression of genes on Hsa21 is regulated by epigenetic mechanisms, and with recent findings of highly recurrent gene-specific changes in DNA methylation patterns in brain and immune system cells with Ts21, the epigenomics of DS has become an active research area. Here we highlight the value of combining human studies with mouse models for defining DS critical genes and understanding the trans-acting effects of a simple chromosomal aneuploidy on genome-wide epigenetic patterning. These genetic and epigenetic studies are starting to uncover fundamental biological mechanisms, leading to insights that may soon become therapeutically relevant.
PMCID:7286740
PMID: 32057305
ISSN: 1875-7855
CID: 5417352
Acute Vertigo from a Unilateral Middle Cerebellar Peduncle Demyelinating Lesion [Meeting Abstract]
Grossman, Scott; Parrotta, Erica; Cho, Catherine; Krieger, Stephen; Rucker, Janet
ISI:000536058000119
ISSN: 0028-3878
CID: 4561002
Spinal epidural lipomatosis with progressive myelopathy in patients with Type 1 Diabetes Mellitus: a novel association? [Meeting Abstract]
Kister, Ilya; Charlson, Robert; Fatterpekar, Girish; Smith, Michael; Shapiro, Maksim; William, Christopher; Lotan, Itay
ISI:000536058004221
ISSN: 0028-3878
CID: 4561452
A real-world study characterizing symptoms and impacts of fatigue in us adults with relapsing multiple sclerosis using a novel disease specific scale [Meeting Abstract]
Azoulai, M.; Levy-Heidmann, T.; Morisseau, V.; Jamieson, C.; Charvet, L.; Krupp, L.; Lair, L.
ISI:000596547102096
ISSN: 1352-4585
CID: 4737212
Demographic and clinical profile of pediatric patients with multiple sclerosis infected with SARS-COV2 [Meeting Abstract]
Schreiner, T.; Chitnis, T.; Tillema, J. -M.; Benson, L.; Gorman, M.; Goyal, M.; Harris, Y.; Krupp, L.; Lotze, T.; Mar, S.; Ness, J.; Rensel, M.; Rodriguez, M.; Shukla, N.; Waubant, E.; Rose, J.; Roalstad, S.; Casper, T. C.
ISI:000596547100178
ISSN: 1352-4585
CID: 4735862
CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA [Meeting Abstract]
Kawakibi, Abed Rahman; Tarapore, Rohinton S.; Gardner, Sharon; Thomas, Chase; Cartaxo, Rodrigo; Yadav, Viveka Nand; Chi, Andrew; Kurz, Sylvia; Wen, Patrick; Arrillaga-Romany, Isabel; Batchelor, Tracy; Butowski, Nicholas; Sumrall, Ashley; Shonka, Nicole; Harrison, Rebecca; de Groot, John; Mehta, Minesh; Odia, Yazmin; Hall, Matthew; Daghistani, Doured; Cloughesy, Timothy; Ellingson, Benjamin; Umemura, Yoshie; Garton, Hugh; Franson, Andrea; Robertson, Patricia; Schwartz, Jonathan; Cantor, Evan; Miklja, Zachary; Mullan, Brendan; Bruzek, Amy; Siada, Ruby; Cummings, Jessica; Paul, Alyssa; Wolfe, Ian; Jiang, Li; Filbin, Mariella; Vats, Pankaj; Kumar-Sinha, Chandan; Mody, Rajen; Chinnaiyan, Arul; Venneti, Sriram; Lu, Guangrong; Mueller, Sabine; Martinez, Daniel; Resnick, Adam; Nazarian, Javad; Waszak, Sebastian; Allen, Joshua; Koschmann, Carl
ISI:000590061300185
ISSN: 1522-8517
CID: 4688082
Initial Data From the Ongoing ENDYMION Open-label Extension Trial of Soticlestat (TAK-935/OV935) in Participants With Developmental and/or Epileptic Encephalopathies (DEE) [Meeting Abstract]
Halford, Jonathan; Arkilo, Dimitrios; Asgharnejad, Mahnaz; Zinger, Celia; Chen, Shijie; During, Matthew; French, Jacqueline
ISI:000536058007166
ISSN: 0028-3878
CID: 4561742
Identification of Specific Circular RNA Expression Patterns and MicroRNA Interaction Networks in Mesial Temporal Lobe Epilepsy
Gray, Lachlan G; Mills, James D; Curry-Hyde, Ashton; Devore, Sasha; Friedman, Daniel; Thom, Maria; Scott, Catherine; Thijs, Roland D; Aronica, Eleonora; Devinsky, Orrin; Janitz, Michael
Circular RNAs (circRNAs) regulate mRNA translation by binding to microRNAs (miRNAs), and their expression is altered in diverse disorders, including cancer, cardiovascular disease, and Parkinson's disease. Here, we compare circRNA expression patterns in the temporal cortex and hippocampus of patients with pharmacoresistant mesial temporal lobe epilepsy (MTLE) and healthy controls. Nine circRNAs showed significant differential expression, including circRNA-HOMER1, which is expressed in synapses. Further, we identified miRNA binding sites within the sequences of differentially expressed (DE) circRNAs; expression levels of mRNAs correlated with changes in complementary miRNAs. Gene set enrichment analysis of mRNA targets revealed functions in heterocyclic compound binding, regulation of transcription, and signal transduction, which maintain the structure and function of hippocampal neurons. The circRNA-miRNA-mRNA interaction networks illuminate the molecular changes in MTLE, which may be pathogenic or an effect of the disease or treatments and suggests that DE circRNAs and associated miRNAs may be novel therapeutic targets.
PMCID:7546880
PMID: 33101384
ISSN: 1664-8021
CID: 4645342